Former Star Ricky Williams Explains NFL’s Stance on Cannabis
On latest Trade To Black podcast, former NFL star Ricky Williams joins us to talk cannabis legalization and the possibility that we might see legislation changes in 2025 for the cannabis industry. Dan Ahrens from AdvisorShares (NYSEARCA: MSOS) also joins us later in the podcast to talk about last weeks performance involving Bright Minds Bioscience (NASDAQ: DRUG) and what investors can anticipate this week regarding the stock.
Early voting is underway in the state of Florida, and on the ballot is the hotly anticipated Amendment 3. Amendment 3 seeks to legalize adult-use cannabis in the state. If the initiative passes, there’s a lot to get excited about, because Florida has the potential to become one of the largest legal cannabis markets in the world.
Prior to becoming such a prominent figure in cannabis advocacy, Ricky Williams was a star running back for the NFL. He’s well known in the industry for his outspoken support for the therapeutic benefits of cannabis, and is also now the CEO and founder of the cannabis brand Highsman.
Hosts Shadd Dales, Anthony Varrell, and Ricky Williams discuss some of the broader implications of the amendment, including how it might push federal cannabis policy towards legislative reforms such as SAFE Banking and rescheduling. But Amendment 3 isn’t the only source of influence. Ricky Williams also weighs in on how popular support from other areas, such as the NFL, will help progress.
Other athletes can help move the needle in their respective sports by helping advocate. The NFL, Ricky says, has already begun to relax some of their policies around testing, and doctors have begun discussing therapeutic benefits. Ricky’s initiative, Project Champion, has been built to help bring other athletes who would like to help educate politicians and advocate for legalization. We’ll find out if and when more NFL stars will join in an effort to create awareness to Congress.
Dan Ahrens explains why Bright Minds Bioscience stock saw a whopping 1800% surge over the past seven days, and what factors are behind it. We’ll also take a general peek at the psychedelics market with Dan, looking at the FDA pipelines, in this episode.